Tokyo, June 26 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000061999) titled 'Longitudinal assessment of CircuLAting Minimal residual disease in advanced non-small cell lung cancer receiving immune-checkPoint inhibitors: a prospective observational study [CLAMP] (WJOG23325L)' on June 26.
Study Type:
Observational
Primary Sponsor:
Institute - West Japan Oncology Group
Condition:
Condition - Advanced NSCLC
Classification by malignancy - Malignancy
Genomic information - NO
Objective:
Narrative objectives1 - To evaluate the association between the detection status of minimal residual disease (MRD) using Myriad's tumor-informed assay and prognosis in patients with advanced or recurrent non-smal...